Tissue plasminogen activator associated pulmonary hemorrhage in patient with ACTA2-associated arteriopathy

Tissue plasminogen activator associated pulmonary hemorrhage in patient with ACTA2-associated arteriopathy

Pulmonary hemorrhage after administration of tissue plasminogen activator (tPA) is a rare complication. We present a 15-year-old boy with a heterozygous pathogenic variant in ACTA2 who presented with right brachial artery aneurysm thrombosis treated initially with tPA, resulting in pulmonary hemorrh...

Full description

Saved in:
Bibliographic Details
Main Authors: Travis G. Hughes, MD, Mark A. Wurth, MD, PhD, Mary B. Sheppard, MD
Format: Article
Language:English
Published: Elsevier 2024-12-01
Series:Journal of Vascular Surgery Cases and Innovative Techniques
Subjects:
ACTA2
Pulmonary hemorrhage
Brachial artery aneurysm
Thrombosis
Online Access:http://www.sciencedirect.com/science/article/pii/S2468428724001424
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Pulmonary hemorrhage after administration of tissue plasminogen activator (tPA) is a rare complication. We present a 15-year-old boy with a heterozygous pathogenic variant in ACTA2 who presented with right brachial artery aneurysm thrombosis treated initially with tPA, resulting in pulmonary hemorrhage. We hypothesize that the underlying pulmonary abnormalities caused by the pathogenic ACTA2 variant may be a risk factor for pulmonary hemorrhage after tPA administration.
ISSN:2468-4287

Similar Items